Berlin - Delayed Quote EUR
Trulieve Cannabis Corp (T0A.BE)
4.2120
+0.2020
+(5.04%)
At close: May 16 at 7:31:05 PM GMT+2
Loading Chart for T0A.BE
- Previous Close
4.0100 - Open
4.1400 - Bid 3.8120 x --
- Ask 4.1820 x --
- Day's Range
4.1320 - 4.2860 - 52 Week Range
2.8080 - 12.5800 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 4, 2025 - Aug 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: T0A.BE
View MorePerformance Overview: T0A.BE
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
T0A.BE
6.19%
S&P/TSX Composite index (^GSPTSE)
5.49%
1-Year Return
T0A.BE
64.58%
S&P/TSX Composite index (^GSPTSE)
16.47%
3-Year Return
T0A.BE
69.74%
S&P/TSX Composite index (^GSPTSE)
28.53%
5-Year Return
T0A.BE
83.55%
S&P/TSX Composite index (^GSPTSE)
77.42%
Compare To: T0A.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
4.2120
+5.04%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
3.9200
+3.70%
Mkt Cap EUR 464.304M
Industry Drug Manufacturers—Specialty & Generic
0.4066
+8.37%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4100
+6.49%
Mkt Cap EUR 449.278M
Industry Drug Manufacturers—Specialty & Generic
0.4390
+13.41%
Mkt Cap EUR 449.281M
Industry Drug Manufacturers—Specialty & Generic
0.2600
+4.00%
Mkt Cap 84.595M
Industry Drug Manufacturers—Specialty & Generic
0.6800
+9.68%
Mkt Cap CAD 701.821M
Industry Drug Manufacturers—Specialty & Generic
0.4950
+12.50%
Mkt Cap 502.875M
Industry Drug Manufacturers—Specialty & Generic
Statistics: T0A.BE
View MoreValuation Measures
As of 5/16/2025
Market Cap
759.61M
Enterprise Value
1.20B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.76
Price/Book (mrq)
0.73
Enterprise Value/Revenue
1.13
Enterprise Value/EBITDA
4.90
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--